Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Christina Robbins

Physician Assistant, Medical Kailua, HI Physician Assistant

NPI 1831548411 CMS profile 11014803

642 Ulukahiki St, Suite 104, Kailua, HI 96734

Open in the dashboard

General payments

$5,619

223 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Christina Robbins of Kailua, HI is reported in the CMS Open Payments database as having received $5,619 across 223 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 90th percentile of Physician Assistant, Medical profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,166 46
2024 General $834 29
2023 General $1,603 63
2022 General $1,130 45
2021 General $887 40

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Christina Robbins
  • Physician Assistant, Medical median
  • Middle half of Physician Assistant, Medical
  • National median

In program year 2025, general payments to Christina Robbins were reported at $1,166. Among 16,675 Physician Assistant, Medical profiles paid that year, the median was $214 and the middle half received between $62 and $755.

Show as a table
Year Christina Robbins Physician Assistant, Medical median Middle half National median
2019 $0 $61 $19–$193 $163
2020 $0 $20 $14–$64 $114
2021 $887 $156 $41–$563 $132
2022 $1,130 $185 $55–$649 $149
2023 $1,603 $199 $58–$717 $160
2024 $834 $206 $62–$740 $164
2025 $1,166 $214 $62–$755 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. AbbVie, Inc. $1,199 61 payments
  2. Regeneron Healthcare Solutions, Inc. $855 19 payments
  3. LEO Pharma Inc. $484 28 payments
  4. Genzyme Corporation $470 12 payments
  5. Amgen Inc. $432 17 payments
  6. Lilly USA, LLC $383 14 payments
  7. Galderma Laboratories, L.P. $324 12 payments
  8. Novartis Pharmaceuticals Corporation $310 19 payments
  9. UCB, Inc. $269 6 payments
  10. Sun Pharmaceutical Industries Inc. $159 3 payments
  11. Other $734 32 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $5,570 219 payments
  2. Education $49 4 payments
Products named General payments · program years 2021–2025
  1. SKYRIZI $751 31 payments
  2. DUPIXENT Inflammation And Immunology $599 13 payments
  3. DUPIXENT Immunology $596 13 payments
  4. Otezla $432 17 payments
  5. ADBRY $405 24 payments
  6. RINVOQ $378 17 payments
  7. TALTZ $328 12 payments
  8. Bimzelx $269 6 payments
  9. DUPIXENT Immunology And Inflammation $256 6 payments
  10. COSENTYX $247 16 payments
  11. Other $2,219 108 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 9 drugs

Part D claims

293

Median for Physician Assistant: 241

Drug cost

$199,272

Median for Physician Assistant: $4,110

Branded share of claims

20.1%

Median for Physician Assistant: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Dupixent Pen Dupilumab Brand 45 $189,899
Tretinoin Generic 44 $3,234
Desonide Generic 31 $1,906
Triamcinolone Acetonide Generic 27 $973
Ketoconazole Generic 45 $965
Fluocinonide Generic 24 $915
Fluorouracil Generic 11 $603
Mupirocin Generic 52 $445
Valacyclovir Valacyclovir Hcl Brand 14 $332

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 15 billing codes

Paid by Medicare

$16,327

Medicare's payments for the services billed

Medicare patients

116

Average age 74

Services billed

387

70 women, 46 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 62%
Arthritis 39%
Chronic kidney disease 23%
Osteoporosis 23%
Ischemic heart disease 21%
Diabetes 17%
Cancer 15%
Atrial fibrillation 14%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 17 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
DUPIXENT
  • GENZYME CORPORATION $118
  • Regeneron Healthcare Solutions, Inc. $66
$184 45 —
SKYRIZI
  • AbbVie, Inc. $164
$164 — —
RINVOQ
  • AbbVie, Inc. $138
$138 — —
Bimzelx
  • UCB, Inc. $79
$79 — —
Otezla
  • Amgen Inc. $44
$44 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See all 17 in the dashboard with a free account

Records

223 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant, Medical in Hawaii

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record